Related references
Note: Only part of the references are listed.A Pilot Study of the Effect of Daikenchuto on Rectal Sensation in Patients with Irritable Bowel Syndrome
Andres Acosta et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2016)
A Randomized Trial of 5-Hydroxytryptamine(4)-Receptor Agonist, YKP10811, on Colonic Transit and Bowel Function in Functional Constipation
Andrea Shin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Pharmacologic inhibition of intestinal sodium uptake: a gut centric approach to sodium management
Andrew G. Spencer et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Tenapanor hydrochloride for the treatment of constipation-predominant irritable bowel syndrome
Marta Zielińska et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases
A. Jarmuz et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2015)
Current and Emerging Treatments for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: Focus on Prosecretory Agents
Rachel H. Thomas et al.
PHARMACOTHERAPY (2015)
Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation
Paula Mosinska et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspective
Paula Mosinska et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2015)
Metabolic Kinetics of 5-Hydroxytryptamine and the Research Targets of Functional Gastrointestinal Disorders
Fuchun Jing et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Pharmacological profile of DA-6886, a novel 5-HT4 receptor agonist to accelerate colonic motor activity in mice
Min Jung Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine
Kara Gross Margolis et al.
GUT (2014)
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides
J. Fichna et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Influence of a new 5-HT4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation
M. Gilet et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation
J. Iturrino et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Bowel Functions, Fecal Unconjugated Primary and Secondary Bile Acids, and Colonic Transit in Patients With Irritable Bowel Syndrome
Andrea Shin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Elobixibat for the treatment of constipation
Banny S. Wong et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets
Gary M. Mawe et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice
J. Fichna et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis
Giovanni M. Pitari
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
Robert W. Busby et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome
Michael Camilleri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea
Banny S. Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Activation of Colonic Mucosal 5-HT4 Receptors Accelerates Propulsive Motility and Inhibits Visceral Hypersensitivity
Jill M. Hoffman et al.
GASTROENTEROLOGY (2012)
Brain-gut interactions in IBS
Jakub Fichna et al.
FRONTIERS IN PHARMACOLOGY (2012)
Defining a responder in treatment trials for chronic idiopathic constipation
S. Raja et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation - a double-blind study
M. Simren et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Females With Functional Constipation
Banny S. Wong et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Neuropsychiatric Adverse Effects of Centrally Acting Antiobesity Drugs
Pradeep J. Nathan et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
Transmembrane guanylate cyclase in intestinal pathophysiology
Kris A. Steinbrecher et al.
CURRENT OPINION IN GASTROENTEROLOGY (2011)
Emerging Pharmacological Therapies for the Irritable Bowel Syndrome
Monthira Maneerattanaporn et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2011)
Neuronal stimulation with 5-hydroxytryptamine 4 receptor induces anti-inflammatory actions via α7nACh receptors on muscularis macrophages associated with postoperative ileus
Yasuaki Tsuchida et al.
GUT (2011)
Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome
William D. Chey et al.
GUT AND LIVER (2011)
Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation
Maria Vazquez Roque et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Metabolism and Pharmacokinetics of Naronapride (ATI-7505), a Serotonin 5-HT4 Receptor Agonist for Gastrointestinal Motility Disorders
S. Scott Bowersox et al.
DRUG METABOLISM AND DISPOSITION (2011)
Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study
M. Goldberg et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
The effect of mosapride citrate on constipation in patients with diabetes
Naohiko Ueno et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit
Robert W. Busby et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders
Noriaki Manabe et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis
Archana S. Rao et al.
GASTROENTEROLOGY (2010)
Cannabinoids and the gut: New developments and emerging concepts
Angelo A. Izzo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study
P. M. Hellstrom et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Defective jejunal and colonic salt absorption and alteredNa(+)/H+ exchanger 3 (NHE3) activity in NHE regulatory factor 1 (NHERF1) adaptor protein-deficient mice
N. Broere et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2009)
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake
Carol Addy et al.
CELL METABOLISM (2008)
Serotonergic agents and the irritable bowel syndrome: what goes wrong?
Robin Spiller
CURRENT OPINION IN PHARMACOLOGY (2008)
The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity
J. A. M. Smith et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
The in vivo gastrointestinal activity of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity
D. T. Beattie et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome
P. M. Hellstrom et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
Morphometric evaluation of oesophageal wall in patients with nutcracker oesophagus and ineffective oesophageal motility
H. S. Kim et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
Effect of itopride hydrochloride on the ileal and colonic motility in guinea pig in vitro
Hyun Chu Lim et al.
YONSEI MEDICAL JOURNAL (2008)
Effects of the novel 5-HT3 agonist MKC-733 on the rat, mouse and guinea pig digestive tract
Navinisha Chetty et al.
PHARMACOLOGY (2008)
Pharmacodynamic effects of a novel prokinetic 5-HT4 receptor agonist, ATI-7505, in humans
M. Camilleri et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2007)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome
W Atkinson et al.
GASTROENTEROLOGY (2006)
Costs of irritable bowel syndrome in the UK and US
S Maxion-Bergemann et al.
PHARMACOECONOMICS (2006)
Effect of MKC-733, a 5-HT3 receptor partial agonist, on bowel motility and symptoms in subjects with constipation:: an exploratory study
T Fujita et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2005)
Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients
Z Liu et al.
MOVEMENT DISORDERS (2005)
Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans
NS Coleman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Effects of mosapride citrate, a 5-HT4 receptor agonist, on colonic motility in conscious guinea pigs
A Inui et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2002)
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
AA Izzo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Share Paper
